New report provides evidence that marijuana effects on health could be more beneficial than harmful. A cancer patient from Canada claimed cannabis oil effectively treated the wound caused by his disease that other drugs failed to treat.

The 44-year-old patient suffered from oral cancer. The disease caused a large hole on his cheek which the cannabis oil reportedly helped to slightly reduce the size.

The drug also reduced the pain caused by the wound. Previous studies already showed marijuana effects could treat pain caused by cancer.

Lawmakers say they need more time to make medical marijuana work.

North Dakota lawmakers are claiming they need for more time to implement the state’s new medical marijuana program.

According to the Associated Press, a joint session was recently held between the House and Senate in an effort to prolong the state's total prohibitionary standard.

Democrats and Republicans are blown away by the fact that marijuana legalization was actually approved in the election last November, are now trying to apply the brakes in order to give state health officials and law enforcement time to get up to speed.

Two more licensed medical marijuana producers have voluntarily recalled hundreds of grams of the drug after traces of a controversial pesticide banned in Canada were detected in their supply, raising questions about Ottawa’s oversight of an industry expected to explode with the upcoming legalization of cannabis.

Last week, Organigram, a publicly traded grower based in Moncton, expanded a Dec. 28 recall of a small amount of product to include almost all of its cannabis buds and oils produced in 2016.

Brazilian healthcare regulator Anvisa on Monday said it had issued the country's first license for sale of a cannabis-based drug in the country after years of legal wrangling with patients.

The multiple sclerosis treatment, an oral spray derived from marijuana and developed by Britain's GW Pharmaceuticals PLC, is known as Sativex internationally and will be sold in Brazil under the brand name Mevatyl.

The legal status of cannabis-based drugs has been a thorny issue in Brazil for years, with several patients fighting in the courts to circumvent prohibition. Anvisa has loosened some restrictions in the past two years, allowing patients with medical orders to personally import some drugs derived from marijuana. 

Opponents of the constitutional amendment allowing medical use of marijuana ran some scary TV spots last year, warning that pot shops would pop up near schools, peddling pot-infused candies to kids.

Supporters of the amendment – who prevailed by a comfortable margin at the polls – patiently insisted that they wanted to let doctors prescribe cannabis under controlled circumstances to help terribly ill people for whom benefits outweigh any risks.

It’s been a long struggle. The Legislature authorized use of a “non-euphoric” form of non-smoking marijuana a couple years ago, for patients with severe seizures. More recently, it permitted full-strength cannabis for terminally ill patients, those thought to have less than a year to live.

More than two dozen states in the U.S. have legalized marijuana and millions of people across the nation use the drug each month, but the precise health effects of the drug on those who use it remain a mystery.

Experts say they have only a hazy idea of the drug’s myriad health effects, and argue that federal laws are to be blamed for the issue. Some experts say that the federal government is erecting major barriers to research that would have provided answers to solve the mystery.

A panel of 16 experts warned in a new report that lack of evidence-based information on cannabis and cannabinoids’ health effects poses a public health risk.

Attention deficit hyperactivity disorder is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Treatments vary, but some people use marijuana to help relieve symptoms. ADHD drugs help to correct dopamine levels in the same way that marijuana may help. Use of the drug is controversial and highly debated.
Research about the consequences and effectiveness of using marijuana to treat children, teens, and young adults is mixed.

Attention deficit hyperactivity disorder (ADHD) is a mental health condition affecting around 6-9 percent of children and young adults, and about 5 percent of all adults around the world.

Marijuana use in medicine is now a growing study. However, the classification of marijuana as a schedule 1 drug which means that there is no accepted medical use and a high potential for abuse is hindering further study of the drug and its medical use. A report released on January 12 by the National Academies of Sciences, Engineering and Medicine calls for expanding research on cannabis and its chemical components called cannabinoids.

Marijuana appears to be an effective treatment for chronic pain, nausea and symptoms of multiple sclerosis, concludes a new report from some of the nation’s top doctors and public health experts.

Commissioned by the National Academies of Sciences, Engineering and Medicine, the report says there’s “conclusive or substantial” research backing the effectiveness of cannabis for those three conditions. But it also warns of dangers from marijuana use: an increased risk of car crashes, lower birth weight babies and problems with memory and attention with heavy use. It also found strong connections between heavy cannabis use and the development of schizophrenia and other psychoses.

Courtagen Life Sciences and Medicinal Genomics today announced a partnership with TheAnswerPage.com to provide continuing medical education (CME) credits to physicians and other healthcare professionals for the upcoming CannMed 2017 Personalized Cannabinoid Medicine Conference to be held at the Joseph B. Martin Conference Center at Harvard Medical School in Boston on April 9-11, 2017.